NATCO Pharma Limited announces the launch of additional strengths for the generic version of Revlimid (lenalidomide capsules), in 2.5 mg, and 20 mg strengths, in the United States, via an exchange filing.
The launch is through its marketing partner Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.
With this launch the companies made available all the strengths of lenalidomide in the US market.
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
Hamirpur Tragedy: Lightning Strike Kills 1, Injures Several Paddy Farmers In Field
UP News: Barabanki Farmer Attempts Suicide Over Alleged Biased Land Order By Former Tehsildar; Probe Ordered
UP News: Lucknow Rises To 3rd Cleanest City In India In Swachh Survekshan 2024, Leaps 41 Spots
UP News: Air India Express Flight Aborts Takeoff In Lucknow; 30 Cancellations In 30 Days Amid Rising Passenger Complaints
